Literature DB >> 21293286

Clinical significance of astrocyte elevated gene-1 expression in human epithelial ovarian carcinoma.

Fanling Meng1, Chang Luo, Lihua Ma, Yuanlong Hu, Ge Lou.   

Abstract

Astrocyte elevated gene-1 (AEG-1) plays an important role in tumor progression including transformation, evasion of apoptosis, invasion, metastasis, and chemoresistance. However, the expression of AEG-1 in ovarian carcinoma and its significance are still unclear. The aim of this study was to examine the expression of AEG-1 in ovarian carcinoma. Immunohistochemistry was performed to determine the expression of AEG-1 in 81 ovarian carcinoma specimens. The correlation of AEG-1 expression with clinicopathological parameters was assessed using χ2 analysis. Patient survival was analyzed using the Kaplan-Meier and log-rank tests. Cox regression was used for the multivariate analysis of prognostic factors. High expression of AEG-1 was detected in 66.67% of the ovarian carcinomas and was significantly associated with the International Federation of Gynecology and Obstetrics stage, histological grade, presence of residual tumor after primary surgery, and tumor recurrence. Patients with high AEG-1 expression had significantly poorer overall survival and disease-free survival (both P<0.001) when compared with patients with low expression of AEG-1. The multivariate Cox analysis showed that AEG-1 was an independent factor for both overall survival and disease-free survival (both P<0.001). These results showed that high AEG-1 expression was associated with progression and prognosis of ovarian carcinoma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21293286     DOI: 10.1097/PGP.0b013e3181ffd2f7

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  14 in total

Review 1.  AEG-1/MTDH/LYRIC, the beginning: initial cloning, structure, expression profile, and regulation of expression.

Authors:  Seok-Geun Lee; Dong-Chul Kang; Rob DeSalle; Devanand Sarkar; Paul B Fisher
Journal:  Adv Cancer Res       Date:  2013       Impact factor: 6.242

Review 2.  Drug resistance mediated by AEG-1/MTDH/LYRIC.

Authors:  Xiangbing Meng; Kristina W Thiel; Kimberly K Leslie
Journal:  Adv Cancer Res       Date:  2013       Impact factor: 6.242

Review 3.  The role of MTDH/AEG-1 in the progression of cancer.

Authors:  Xue Shi; Xin Wang
Journal:  Int J Clin Exp Med       Date:  2015-04-15

4.  Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.

Authors:  Xiangbing Meng; Danlin Zhu; Shujie Yang; Xinjun Wang; Zhi Xiong; Yuping Zhang; Pavla Brachova; Kimberly K Leslie
Journal:  J Biol Chem       Date:  2011-12-23       Impact factor: 5.157

5.  Prognostic impact of Metadherin-SND1 interaction in colon cancer.

Authors:  Nan Wang; Xilin Du; Li Zang; Nuan Song; Tao Yang; Rui Dong; Tao Wu; Xianli He; Jianguo Lu
Journal:  Mol Biol Rep       Date:  2012-10-14       Impact factor: 2.316

6.  Astrocyte elevated gene-1: a novel independent prognostic biomarker for metastatic ovarian tumors.

Authors:  Cong Li; Kexin Chen; Jianping Cai; Qing-Tao Shi; Yinghong Li; Lejing Li; Hongtao Song; Huilei Qiu; Yu Qin; Jing-Shu Geng
Journal:  Tumour Biol       Date:  2014-04

Review 7.  MicroRNAs in cancer diagnosis and therapy: from bench to bedside.

Authors:  Isamu Hoshino; Hisahiro Matsubara
Journal:  Surg Today       Date:  2012-11-06       Impact factor: 2.549

8.  Metadherin contributes to the pathogenesis of diffuse large B-cell lymphoma.

Authors:  Xueling Ge; Xiao Lv; Lili Feng; Xiaoqian Liu; Junming Gao; Na Chen; Xin Wang
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

9.  The MTDH (-470G>A) polymorphism is associated with ovarian cancer susceptibility.

Authors:  Cunzhong Yuan; Xiao Li; Shi Yan; Qifeng Yang; Xiaoyan Liu; Beihua Kong
Journal:  PLoS One       Date:  2012-12-11       Impact factor: 3.240

10.  Metadherin, p50, and p65 expression in epithelial ovarian neoplasms: an immunohistochemical study.

Authors:  Ioanna Giopanou; Vasiliki Bravou; Panagiotis Papanastasopoulos; Ioannis Lilis; Panagiotis Aroukatos; Dionysios Papachristou; Sophia Kounelis; Helen Papadaki
Journal:  Biomed Res Int       Date:  2014-05-22       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.